Collectively, these clinical reports demonstrate that some CYBB mutations induce only partial loss of NAPDH function, which results in less severe phenotypes; however, this residual NAPDH oxidase activity is not sufficient to completely protect the patient against infections. The gene discussed is CYBB; the disease is infection.